BioSpace News Archive

Valbiotis Announces That It Has Submitted to the Competent Authorities the Three Clinical Protocols for TOTUM•854 Indicated in the Reduction of Blood Pressure and Presents Its Comprehensive Clinical Development Plan

Valbiotis announces that it has submitted the three clinical protocols for TOTUM•854, indicated in the reduction of blood pressure, to the competent authorities and presents its comprehensive clinical development plan, as announced at the annual meeting of the European Society of Hypertension and of the International Society of Hypertension in April 2021.

December 1, 2021
·
7 min read
Business

Horizon Therapeutics plc Provides Academic Scholarships to Help Economically Disadvantaged Students in Ireland Further Their STEM Education

Horizon Therapeutics plc (Nasdaq: HZNP) today announced $140,000 in scholarships to help economically disadvantaged students from Trinity College Dublin and Waterford Institute of Technology cover their non-tuition expenses.

December 1, 2021
·
3 min read
Great Bay Bio Completes a Near USD 10M Series A Fundraising

Great Bay Bio (hereinafter referred to as “GBB”) is pleased to announce today the completion of its near USD 10M series A fundraising led by Proxima Ventures.

December 1, 2021
·
4 min read
XNK Therapeutics to present at ABGSC Private Companies Seminar on December 6

XNK Therapeutics AB’s CEO, Johan Liwing , will present at the ABGSC Private Companies event on December 6.

December 1, 2021
·
1 min read
Eurofins Technologies Launches New Multiplex RT-PCR Respiratory Panel for SARS-CoV-2, Flu A, Flu B, RSV A and RSV B

Eurofins Technologies announces the launch of two RT-PCR assays to accurately diagnose respiratory diseases caused by SARS-CoV-2, Influenza virus or RSV.

December 1, 2021
·
2 min read
Empower Clinics Successfully Completes Health Canada Review To Sell Covid-19 At-Home Saliva Collection Kit

EMPOWER CLINICS INC. is pleased to announce that it is has received approval from Health Canada to proceed under the original Device Class I authorization for Kai Care COVID-19 At-Home Saliva Collection Kit (“Kai Care Kits”).

December 1, 2021
·
4 min read
Policy

U.S. FDA Grants Bionomics Fast Track Designation to BNC210 for the Acute Treatment of Social Anxiety Disorder and Other Anxiety Related Disorders

Bionomics Limited, a clinical-stage biopharmaceutical company, is pleased to announce that the U.S. Food and Drug Administration has granted Fast Track designation to the BNC210 development program for the acute treatment of Social Anxiety Disorder and other anxiety-related disorders.

December 1, 2021
·
6 min read
Business

Biodesix Partners with Spesana to Streamline Digital Access to Molecular Diagnostics for Precision Medicine in Lung Cancer

Spesana and Biodesix Inc. announced today that they have partnered to further streamline and automate the use of molecular diagnostics in clinical workflows across the United States utilizing Spesana’s digital platform solutions for comprehensive lung cancer.

December 1, 2021
·
6 min read
Human Insulin Market: Introduction of the Safety Pen Needles and Pen Devices for Effective Delivery of Insulin to Drive the Market

Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.

December 1, 2021
·
6 min read
Gene Expression Analysis Market: Rise in the need for personalized medicine is likely to influence the global market

Gene expression makes an analysis of the study of the activity or occurrence of the making of a gene product from its coding gene.

December 1, 2021
·
6 min read